Spontaneous quinolone resistance in Serratia marcescens due to a mutation in gyrA
Open Access
- 1 May 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (5) , 898-902
- https://doi.org/10.1128/aac.35.5.898
Abstract
Spontaneous quinolone-resistant mutants of MP050, a quinolone-susceptible clinical strain of Serratia marcescens, were isolated on nutrient agar containing 0.5 microgram of ciprofloxacin per ml. One mutant, designated MP051, was selected for further study. Quinolone MICs for MP051 were 4- to 16-fold higher than those for MP050; nonquinolone MICs were unchanged. The DNA gyrase isolated from MP051 was 24-fold less sensitive to inhibition of supercoiling by ciprofloxacin than the DNA gyrase isolated from MP050 was. Inhibition studies on reconstituted combinations of heterologous gyrase subunits showed that the decreased inhibition was dependent on the A subunit of DNA gyrase from MP051. Further evidence that this decreased inhibition was due to a gyrA mutation was provided by analysis of Escherichia coli gyrA gene expression in S. marcescens heterodiploids containing pNJR3-2, a broad-host-range gyrA gene probe. Quinolone susceptibilities of MP051 heterodiploids containing the wild-type E. coli gyrA gene decreased to those of MP050, while quinolone susceptibilities of MP050 containing the same plasmid were unchanged. These results indicate that spontaneous quinolone resistance in MP051 was due to a mutation in gyrA.Keywords
This publication has 33 references indexed in Scilit:
- Broad-host-range gyrase A gene probeAntimicrobial Agents and Chemotherapy, 1990
- Analysis of acquired ciprofloxacin resistance in a clinical strain of Pseudomonas aeruginosaAntimicrobial Agents and Chemotherapy, 1990
- In vitro emergence of quinolone-resistant mutants of Escherichia coli, Enterobacter cloacae, and Serratia marcescensAntimicrobial Agents and Chemotherapy, 1990
- Quinolone resistance in clinical isolates of Serratia marcescensAntimicrobial Agents and Chemotherapy, 1989
- Some Properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with Non-Enzyme-Dependent Multiple Resistance to -Lactam Antibiotics, Aminoglycosides, and QuinolonesClinical Infectious Diseases, 1988
- Isolation and characterization of norfloxacin-resistant mutants of Escherichia coli K-12Antimicrobial Agents and Chemotherapy, 1986
- Emergence of Resistance to -Lactams, Aminoglycosides, and Quinolones During Combination Therapy for Infection Due to Serratia marcescensThe Journal of Infectious Diseases, 1986
- Elimination of plasmids by new 4-quinolonesAntimicrobial Agents and Chemotherapy, 1985
- Incomplete Cross-Resistance of Nalidixic and Pipemidic Acid-Resistant Variants of Serratia marcescens Against Ciprofloxacin, Enoxacin, and NorfloxacinChemotherapy, 1985
- Properties of a supercoiled deoxyribonucleic acid-protein relaxation complex and strand specificity of the relaxation eventBiochemistry, 1970